RAMETTA, RAFFAELA
RAMETTA, RAFFAELA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
2021-03-23 K.J. Kim, J.K. Kang, Y.H. Jung, S.B. Lee, R. Rametta, P. Dongiovanni, L. Valenti, U.B. Pajvani
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011-10-01 L.V.C. Valenti, R. Rametta, M. Ruscica, E. Canavesi, A.L. Fracanzani, P. Dongiovanni, P. Magni, S.R. Fargion
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011-03-01 L.V.C. Valenti, R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011-02-01 R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion, L.V.C. Valenti
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live
2011-12-01 L.V.C. Valenti, V. Nobili, A. Al-Serri, R. Rametta, J.B. Leathart, M.A. Zappa, P. Dongiovanni, A.L. Fracanzani, A. Alterio, G. Roviaro, A.K. Daly, S.R. Fargion, C.P. Day
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease
2010-01-01 L. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, M. Maggioni, A.L. Fracanzani, S. Fargion
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease
2010-04-01 L.V.C. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, A.L. Fracanzani, S.R. Fargion
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease
2010-02-01 E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, A.L. Fracanzani, S.R. Fargion, L.V.C. Valenti
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD
2021-09-01 E. Corradini, E. Buzzetti, P. Dongiovanni, S. Scarlini, A. Caleffi, S. Pelusi, I. Bernardis, P. Ventura, R. Rametta, E. Tenedini, E. Tagliafico, A.L. Fracanzani, S. Fargion, A. Pietrangelo, L. Valenti
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells : effect of mono- and bi-specific somatostatin analogs on cell growth
2014-02-15 M. Ruscica, P. Magni, L. Steffani, F. Gatto, M. Albertelli, R. Rametta, L. Valenti, P. Ameri, V. Magnaghi, M. Culler, F. Minuto, D. Ferone, M. Arvigo
Dietary iron overload induces visceral adipose tissue insulin resistance
2013-06-01 P. Dongiovanni, M. Ruscica, R. Rametta, S. Recalcati, L. Steffani, S. Gatti, D. Girelli, G. Cairo, P. Magni, S. Fargion, L. Valenti
Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (Dios): Two related conditions or different entities?
2020-01-01 R. Rametta, A.L. Fracanzani, S. Fargion, P. Dongiovanni
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis
2012-12-01 L. Valenti, A.L. Fracanzani, R. Rametta, M. Fraquelli, G. Soverini, S. Pelusi, P. Dongiovanni, D. Conte, S. Fargion
From Environment to Genome and Back : a Lesson from HFE Mutations
2020-05-01 R. Rametta, M. Meroni, P. Dongiovanni
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
2010-02-01 P. Dongiovanni, L.V.C. Valenti, R. Rametta, A.K. Daly, V. Nobili, E. Mozzi, J.B. Leathart, A. Pietrobattista, A.D. Burt, M. Maggioni, A.L. Fracanzani, E. Lattuada, M.A. Zappa, G. Roviaro, G. Marchesini, C.P. Day, S.R. Fargion
GNPAT p.D519G variant and iron metabolism during oral iron tolerance test
2017-01-01 R. Rametta, P. Dongiovanni, S. Fargion, L. Valenti
GNPAT rs11558492 is not a major modifier of iron status : study of Italian hemochromatosis patients and blood donors
2017-06-01 F. Greni, L. Valenti, R. Mariani, I. Pelloni, R. Rametta, F. Busti, G. Ravasi, D. Girelli, S. Fargion, S. Galimberti, A. Piperno, S. Pelucchi
Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease
2013-08-29 L. Valenti, R.M. Mendoza, R. Rametta, M. Maggioni, C. Kitajewski, C.J. Shawber, U.B. Pajvani
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance
2014-07-01 R. Rametta, M. Ruscica, P. Dongiovanni, C. Macchi, A.L. Fracanzani, L. Steffani, S. Fargion, P. Magni, L. Valenti
Hepcidin resistance in dysmetabolic iron overload
2016-10-01 R. Rametta, P. Dongiovanni, S. Pelusi, P. Francione, F. Iuculano, V. Borroni, E. Fatta, A. Castagna, D. Girelli, S. Fargion, L. Valenti